Related by context. All words. (Click for frequent words.) 66 Amrubicin 65 pegylated liposomal doxorubicin 64 Fc fusion protein 64 amrubicin 64 HSP# inhibitor 63 platinum chemotherapeutic 63 Irinotecan 62 liposomal formulation 62 Luteinizing Hormone Releasing Hormone 62 XYOTAX TM 62 epothilone 62 Ixabepilone 62 PPAR gamma agonists 62 maturation inhibitors 61 humanized monoclonal 61 antisense drug 61 EndoTAG TM -1 61 potent antiproliferative 61 volociximab 61 antibody MAb 61 Cx# [002] 61 RhuDex ® 61 EOquin TM 61 vidofludimus 61 Clofarabine 61 radiolabeled 61 HuMax CD4 60 mesylate 60 Mipomersen 60 Aflibercept 60 BCR ABL inhibitors 60 PEGylated interferon 60 Aplidin 60 YONDELIS R 60 metastatic renal cell carcinoma 60 Aptivus ® 60 Akt inhibitor 60 Vernakalant 60 SERMs 60 glycosylated 60 synthetic retinoid 60 proteasome inhibitor 60 chimeric monoclonal antibody 60 PDE4 inhibitor 60 subcutaneously administered 60 fluoropyrimidine 59 Thrombin 59 docetaxel Taxotere ® 59 peptide conjugated 59 somatostatin analogue 59 MEK inhibitors 59 Oncaspar 59 Imprime PGG 59 receptor tyrosine kinase inhibitor 59 YONDELIS 59 Leukine ® 59 Liposomal 59 Prolastin A1PI 59 Allovectin 7 59 GW# [003] 59 GHRH 59 Bendamustine 59 DU #b 59 bevacizumab Avastin ® 59 Allovectin 7 ® 59 Nexavar ® 59 DUROS 59 MYDICAR ® 59 anti CD3 59 beta 1a 59 SIR Spheres 59 Pitavastatin 59 Hsp# Inhibitor 59 prostone 59 cleavable linker 59 BiTE 58 bioabsorbable polymer 58 motexafin gadolinium 58 ceftazidime 58 HuMax 58 IV Busulfex 58 antimitotic 58 MET inhibitor 58 Dalbavancin 58 parthenolide 58 paclitaxel carboplatin 58 inhaled treprostinil 58 cytotoxicity assays 58 inhaled AAT 58 IFN α 58 mineralocorticoid receptor 58 monoclonal anti 58 immunomodulatory therapy 58 EOquin 58 PN# [001] 58 HCV protease inhibitors 58 carboplatin paclitaxel 58 Xanafide 58 CIMZIA ™ 58 Syncria 58 melphalan prednisone 58 Dacogen decitabine 58 Gliadel Wafer 58 Edoxaban 58 rilpivirine 58 Recombinant Human 58 PPAR gamma agonist 58 Kahalalide F 58 selective orally bioavailable 58 RECOTHROM R 58 mutant KRAS 58 UPLYSO 57 PROCHYMAL 57 paclitaxel poliglumex 57 Onconase 57 Nippon Shinyaku 57 orally administered inhibitor 57 tumor specific antigen 57 Blinatumomab 57 canakinumab 57 MCF7 57 Mycophenolate Mofetil 57 synthetic peptide containing 57 KNS # 57 rxRNA 57 PTH analogue 57 transfection reagents 57 Aurora Kinase 57 Elvitegravir 57 EP #R 57 siRNAs targeting 57 LHRH antagonist 57 Cyclosporin 57 Aplidin R 57 eluting stent 57 Quinamed 57 Civacir 57 lipid nanoparticle 57 ATD Gel 57 Teysuno 57 ELACYT 57 TREANDA 57 MyoCell SDF 1 57 RAV# 57 Anticalins R 57 Relivar 57 CBLC# 57 selective antagonist 57 Proxinium TM 57 OncoGel 57 HDACi 57 Neupogen ® 57 Brinavess 57 TASQ 57 BRIM2 57 buccal spray 57 Zavesca r 57 KRAS mutations occur 57 intravenous AAT 57 Onalta 57 HuMax EGFr 57 anti neoplastic 57 orally dosed 57 recombinant antibodies 57 Anavex #-# 57 AChE inhibitors 57 ARIKACE ™ 57 vascular disrupting agent 56 unmutated 56 lanreotide 56 Archexin 56 acyclovir Lauriad R 56 Nimotuzumab 56 AQ4N 56 Chinese Hamster Ovary 56 mapatumumab 56 liposomal delivery 56 octreotide 56 Plenaxis TM 56 INT# [002] 56 Miltefosine 56 Onalta ™ 56 Nalmefene 56 Clevudine 56 IRESSA 56 TheraCIM 56 5 HT3 antagonist 56 Traficet EN 56 Alfacell proprietary ribonuclease 56 mertansine 56 IMC A# 56 VDAs 56 PrevOnco 56 antibody cytokine 56 ritonavir boosted 56 ospemifene 56 Factor VIIa 56 mitomycin 56 LentiVector 56 diclofenac sodium 56 Exendin 4 56 antitumour 56 somatostatin analog 56 PORxin TM 56 selective androgen receptor modulator 56 semisynthetic 56 BAY #-# 56 comparator arm 56 Litx 56 sargramostim 56 everolimus eluting stent 56 cephalosporin antibiotic 56 Mimpara 56 TroVax ® 55 PhiloGene 55 SYN# 55 multikinase inhibitor 55 KRN# 55 MedPulser 55 Granulocyte Colony Stimulating Factor 55 Cyclosert TM 55 CIMZIA TM 55 Onalta TM 55 HepDirect prodrug 55 BrachySil TM 55 metastatic RCC 55 orally disintegrating 55 beta estradiol 55 PEGylated 55 Ophena 55 Tofacitinib 55 intravesical instillation 55 proteasome inhibitor bortezomib 55 Sym# 55 miglustat 55 Tacrolimus 55 oncolytic vaccine 55 PSN# [001] 55 pegylated recombinant 55 ADP receptor antagonist 55 MOVIPREP R 55 Pradefovir 55 Genz # 55 fallopian tube cancers 55 EndoTAG TM 55 Triphendiol 55 peripherally acting 55 CINTREDEKIN BESUDOTOX 55 Cladribine 55 Fluconazole 55 Cleviprex TM clevidipine 55 phase IIb clinical 55 Capesaris 55 apaziquone 55 RELISTOR ® 55 Resten NG 55 Solazed 55 recombinant insulin 55 Zirgan 55 CCR5 antagonist 55 Locked Nucleic Acid LNA 55 relapsing multiple sclerosis 55 Glufast 55 PF # [001] 55 Multimeric 55 iPSC 55 BrachySil ™ 55 darunavir r 55 Abbokinase 55 tumorigenicity 55 ART# 55 Sanvar R 55 DURIN 55 renin inhibitor 55 SERCA2a 54 HuMax CD# 54 Symadex 54 PGL# 54 prodrugs 54 Phase #b/#a clinical 54 platelet inhibitor 54 Cloretazine 54 NTDDS 54 developing TB4 54 RenaZorb 54 LB# [003] 54 trastuzumab Herceptin R 54 Diamyd R 54 Dabigatran etexilate 54 TMC# [002] 54 GeneICE 54 pain palliation 54 Myolimus 54 RenaZorb TM 54 fenretinide 54 therapeutic monoclonal antibody 54 tolperisone 54 Src inhibitors 54 Myelodysplastic Syndrome MDS 54 Ostabolin C TM 54 Maxy G# 54 VPRIV 54 Glufosfamide 54 Onco TCS 54 fosbretabulin 54 blood clot dissolver 54 immunotherapeutic vaccine 54 Micromet BiTE 54 DP b# 54 Angiocept 54 capecitabine Xeloda 54 DB# [003] 54 candidate TNFerade biologic 54 synthetic analogues 54 TAXOTERE R 54 lorvotuzumab mertansine 54 Homspera TM 54 cathepsin K inhibitor 54 intravenously administered 54 OMP #M# 54 Apo2L 54 Cypher Stent 54 octreotide implant 54 topical NSAID 54 Atrasentan 54 subcutaneous immunoglobulin 54 DEB# 54 mild vasodilator 54 GRN# 54 hMG 54 bardoxolone 54 XTEN 54 GSK# [001] 54 paricalcitol 54 PrevOnco ™ 54 Isolagen Process 54 cancer immunotherapies 54 PROMUS Element 54 DURIN TM 54 Vantas 54 TG# [001] 54 Alvesco R 54 regorafenib 54 CCX# 54 XIENCE V stent 54 CCR5 inhibitor 54 M Vax 54 Xelox 54 Cethromycin 54 CytoSorb TM 54 prodrug 54 ZACTIMA 54 Factor Xa inhibitor 53 cell lysate 53 BEMA TM Fentanyl 53 candidate deforolimus 53 Nanobody 53 drug eluting stent DES 53 TRX1 53 synthetic peptides 53 Xerecept 53 topically administered 53 Emezine 53 AEGR 53 Virulizin R 53 sunitinib malate 53 Collategene 53 humanised monoclonal antibody 53 selective agonists 53 HuMax TAC 53 OXIGON TM 53 hapten 53 #D#C# 53 Zysolin TM 53 LT NS# 53 LPV r 53 immunotherapeutics 53 hypoxia activated prodrug 53 HCD# [002] 53 Optiquel ™ 53 PICM #H 53 NurOwn 53 eligen 53 ZFP TF 53 ESPRIT exon skipping 53 chemoradiation therapy 53 OZURDEX ® 53 hereditary deficiency 53 Genzyme Synvisc 53 FOR FURTHER INFORMATION ABOUT 53 Pharmacokinetic studies 53 transdermal gel 53 Chemophase 53 recombinant factor VIIa 53 Bioral ® 53 MT# MEDI 53 IMC #F# 53 Bioral 53 Eligard ® 53 piperacillin tazobactam 53 afamelanotide 53 dose escalation clinical 53 Elitek 53 ReN# 53 GnRH antagonist 53 TYZEKA 53 DOS# 53 glycosylation profile 53 Catena ® 53 novel oral anticoagulant 53 Cerashield 53 hepatoma 53 buccal delivery 53 Transfluor 53 Increlex R 53 AP# [003] 53 Medarex UltiMAb R 53 tolevamer 53 StemEx 53 MKC# MKC# PP 53 Sebivo 53 Metvix 53 Iluvien ® 53 Scancell 53 Melphalan 53 mimetics 53 Tev Tropin 53 ibandronate 53 C#T [002] 53 BioMatrix 53 pharmacodynamic PD 53 Immunotherapeutic 53 Targeted Chemotherapy 52 Myeloid 52 Onrigin TM 52 SARMs 52 patented Bioral 52 microwell plate 52 oral taxane 52 methylnaltrexone 52 enzyme rHuPH# 52 BAL# [002] 52 BIO SET 52 redox active 52 EDEMA3 52 ATL/TV# 52 GBM tumors 52 Besivance 52 KL4 Surfactant 52 XIENCE V Everolimus Eluting 52 HYLENEX recombinant 52 MYDICAR 52 Ampligen r 52 Tostrex 52 gastric retentive 52 ISTODAX ® 52 chemical entities NCEs 52 multicenter Phase II 52 NADiA 52 everolimus eluting stents 52 ZEFTERA TM Zevtera TM 52 Orapred ODT 52 Troxatyl 52 IgG1 antibodies 52 Apo AIMilano 52 transdermal spray 52 Prodarsan ® 52 Fenretinide 52 SEPET TM 52 Plasmin 52 Milnacipran 52 constitutively expressed 52 Phase Ib study 52 CLL SLL 52 pegylation 52 X Excite 52 AdvaTab 52 voclosporin 52 beta islets 52 recombinant Factor VIII 52 juvenile chondrocytes 52 administered subcutaneously 52 Kamada AAT 52 Affibody ® molecules 52 IAP inhibitor 52 ORMD 52 E1 INT TM 52 Spheramine 52 SuperAntibody 52 TAXUS Liberte 52 oncogene addiction 52 LANTUS ® 52 NLX P# 52 CB2 selective 52 TMC# C# 52 drug eluting coating 52 Anticalin R 52 APTIVUS 52 pharmacokinetic PK study 52 forodesine hydrochloride 52 human secretin 52 inhaled prostacyclin 52 candidates Azedra 52 INOmax 52 pleiotropic 52 darunavir ritonavir 52 biobetter 52 systemic RNAi 52 bovine thrombin 52 Taclonex R 52 drug eluting coronary stent 52 rhFVIIa 52 OvaRex R 52 Delcath PHP System 52 Xcelerant Delivery System 52 Septin9 biomarker 52 Aeroquin 52 Pancreate 52 murine monoclonal antibody 52 pharmacologically active 52 Tavocept 52 romidepsin 52 biologic therapeutics 52 TransMID 52 5 HT2C 52 Fabry Disease 52 ddRNAi 52 candidate Zelrix 52 bioabsorbable stent 52 Ampligen R 52 Pivotal Trial 52 selective receptor agonist 52 Vascular Wrap TM 51 HIV maturation inhibition 51 Lixivaptan 51 potent suppressor 51 chemoprotective 51 Olerup SSP 51 FOCALIN XR 51 interleukin 1ß 51 Firdapse 51 Indaflex TM 51 nab paclitaxel 51 transduced 51 Calcineurin inhibitors 51 Zyclara 51 tesmilifene 51 GORE TAG Device 51 Uplyso 51 selective A2A adenosine receptor 51 Thrombin topical Recombinant 51 Tyzeka Sebivo 51 Biopump 51 TÎ ² 4 51 reteplase 51 NovaBay Aganocide compounds 51 pentostatin 51 SUMAVEL 51 Zilver PTX stent 51 ActA 51 TIMERx 51 Randomised 51 pharmacodynamic profile 51 Cloretazine R VNP#M 51 virosome 51 BioSilicon 51 Sanvar 51 CG# [003] 51 clevidipine 51 placental derived 51 celgosivir 51 MAbs 51 intra arterial 51 Amphinex ® 51 oral antiplatelet agent 51 Parathyroid Hormone 51 Lupuzor 51 purified protein 51 siRNA therapeutic 51 CA4P 51 POMx 51 desonide 51 SynCon 51 RTP #i 51 stated Michelle Berrey 51 Adentri 51 adipiplon 51 hi tech nicotine 51 KN# [001] 51 Psoraxine R 51 #T# L1 51 valopicitabine NM# 51 neuroactive 51 Locked Nucleic Acid 51 REGEN trial 51 proprietary LNA 51 Nanobodies 51 stimulate insulin secretion 51 Talactoferrin 51 XIENCE V PROMUS Stent 51 Kevetrin ™ 51 HepaGam B 51 follicular lymphomas 51 direct thrombin inhibitors 51 lead molecular radiotherapeutic 51 CGRP 51 Solesta 51 diphosphate 51 Preotact 51 FVIIa 51 bioerodible 51 pyrophosphate 51 Initiate Phase 51 ADAGIO study 51 LCP AtorFen 51 OMS# 51 multicentre randomized 51 galactomannan 51 Combo Stent 51 oral ridaforolimus 51 AutovaxID TM 51 reformulates existing FDA 51 ARG# 51 preclinical efficacy 51 Endotis 51 CHO cell 51 Dual Opioid 51 Prefilled Syringe 51 Micropump 51 rusalatide acetate 51 Phase #b/#a 51 Annexin V 51 valtorcitabine 50 genericized 50 Angioblast 50 udenafil 50 Phase III randomized controlled 50 LCP Tacro TM 50 recurrent malignant gliomas 50 TURBO Booster 50 successfully commercialize Iluvien 50 Nasulin ™ 50 TAXUS TM 50 placebo dexamethasone 50 ZYBRESTAT 50 metabolomic profiles 50 Vilazodone 50 prokinetic 50 SGLT2 inhibitor 50 PureGraft ™ 50 TOCOSOL 50 noninferior 50 Zuplenz 50 Curaxin 50 Vascugel 50 Currently RegeneRx 50 Anticalin 50 MultiStat 50 candidate ridaforolimus 50 therapeutic monoclonal antibodies 50 delta opioid receptor 50 XmAb 50 metabolizing enzyme 50 Keryx Biopharma 50 AngioJet R 50 VaxImmune 50 ATryn ® 50 RECOTHROM ® 50 hpSCs 50 Albugon 50 PET tracers 50 HepeX B 50 PROMUS Element Stent 50 phase IIa clinical 50 IFN Beta CTP 50 recombinant antithrombin product 50 anti CD3 monoclonal 50 Phase Ib II 50 CORTOSS R 50 peripheral arterial 50 MyoCell 50 Zemplar Capsules 50 delivers sumatriptan 50 TAXUS Element Paclitaxel Eluting 50 PCA3 assay 50 deferoxamine 50 Radiofrequency Ablation RFA 50 intravenous dosing 50 locoregional disease 50 cariprazine 50 monoclonals 50 PolyActive 50 MVax 50 Solazed ™ 50 VIR# 50 albiglutide 50 elos 50 difluprednate 50 eligen R technology 50 ROCKET AF 50 advanced polymer conjugate 50 Targeted Immunotherapy 50 rFVIIIFc 50 NN# [001] 50 ThermoDox R 50 CyPath ® 50 QTinno TM 50 IFN alpha 2a 50 Intravitreal 50 Alnylam RNAi 50 Somatuline Autogel 50 iSONEP 50 PharmFilm 50 docetaxel cisplatin 50 multicenter randomized placebo controlled 50 pro angiogenic 50 G CSF 50 silibinin 50 INGAP 50 TriActiv R System 50 CardioSEAL 50 Bayer Onyx 50 oral transmucosal 50 molecular imaging radiopharmaceutical 50 Ascendra 50 Inhaled AAT 50 Lucanix 50 Urokinase 50 solithromycin 50 catheter occlusion 50 LCP Tacro 50 II Clinical Trial 50 delipidation 50 mAbs 50 Vascular Wrap 50 polyclonal antibody 50 AMD# [003] 50 Asubio Pharma 50 Angiox R 50 #:# randomization 50 Chemical Vapor Deposition PECVD 50 mSEPT9 biomarker 50 comparator PI r 50 Abstral ® 50 unresectable HCC 50 insulin detemir 50 LEAPS TM 50 Symplicity Catheter System 50 CE Marked 50 MEPACT 50 Amikacin Inhale 50 eplerenone 50 Invicorp 50 CCX# B 50 MICARDIS ® 50 INxin TM 50 Toric IOL 50 Memryte 50 dipeptidyl peptidase IV 50 human C1 inhibitor 50 outlicensed 50 Smarticles 50 sumatriptan injection 50 CIPN 50 Oncoscience AG 50 AZOR 50 Adagen 49 imiglucerase 49 Trinam 49 pancreatic ductal 49 human pluripotent stem 49 Novasome R 49 Nipent R 49 leiomyoma 49 enhanced ADCC antibody 49 Percutaneous Transluminal Coronary Angioplasty 49 nasal antihistamine 49 Brentuximab vedotin 49 Ceflatonin R 49 NEUGENE R 49 Crucell PER.C6 ® 49 zalutumumab 49 polymer platinate 49 biocompatible shelf stable 49 Severe Sepsis 49 ThermaVolt 49 immunodeficient 49 anticancer activity 49 confirmatory Phase III 49 phorbol 49 Cinacalcet HCl 49 Zerenex 49 tipranavir 49 LH RH 49 pegylated liposomal doxorubicin PLD 49 Lipoic Acid 49 Phase IIa trials 49 generation NEUGENE antisense 49 recombinant biopharmaceutical 49 CK # administered 49 ARIKACE 49 ZFP TFs 49 SUTENT ® 49 AtuRNAi 49 Eluting Stent 49 anti muscarinic 49 GlycoPEGylation TM technologies 49 factor VIIa 49 NeoDisc 49 sub licensable 49 BCIRG 49 Phase IIA 49 CollaRx 49 intranasal insulin product 49 HepatAssist 49 Ii Key 49 proprietary PEGylation 49 telomerase activation 49 DAVANAT ® 49 shRNA libraries 49 CERE 49 sirolimus eluting stents 49 Tetrabenazine 49 PREOS R 49 glucokinase activator 49 sitagliptin phosphate 49 Initiated Phase 49 using Crucell PER.C6 49 OraDisc 49 controlled multicenter Phase 49 Ketotransdel 49 aminobutyric acid 49 product platforms AZX# 49 randomized controlled Phase 49 NovoSeven ® 49 transfemoral 49 Vancocin ® 49 BioSilicon TM 49 HeartMate ® 49 cortical stimulation 49 antibody arrays 49 dose escalation Phase 49 phase IIIb 49 Vascugel ® 49 Ruconest 49 Peptide YY #-# 49 SQiDworks 49 HepaGam B R 49 selective A1 adenosine 49 splice variants 49 Febuxostat 49 fully bioabsorbable 49 using VIAdel TM 49 HydroGel 49 Urocidin 49 Uracyst R 49 PDL# 49 abiraterone acetate 49 steroid refractory 49 VeraTag 49 HuCNS SC ® 49 VitroGro 49 personalized dendritic 49 sulfated 49 ATD gel 49 RE LY ® 49 Bavarian Nordic patented 49 hybridoma 49 therapeutically beneficial 49 collagenase 49 proprietary DuraSite ® 49 GLPG# 49 Cytochrome P# 49 peptide receptor 49 chemically synthesized 49 phase Ib 49 CryoSeal 49 recombinant spider silk 49 Axxion TM 49 Sonatherm 49 Rescula 49 Cotara 49 ELONVA 49 PediaFlow 49 administered orally 49 UltiMAb ® 49 RECALL VAX 49 everolimus 48 Evamist TM 48 Resolute DES 48 molecular entities NMEs 48 double blinded placebo 48 forodesine hydrochloride BCX 48 Cerashield ™ 48 SYCREST 48 NanoCrystal ® technology 48 synDNA TM 48 PMED 48 eIF4E 48 Phase IIIb clinical 48 Calmare device 48 BioNumerik 48 PORxin TM platforms 48 Discovery Labs KL4 48 prospective multicenter 48 adipose tissue derived 48 Prednisporin 48 Injection r 48 Teijin Pharma 48 BLP# Liposome Vaccine 48 Captisol ® 48 Indaflex 48 Self Expanding Stent 48 potent antitumor 48 STEDESA 48 Ceplene/IL-2 48 buccal insulin spray 48 BRILINTA 48 MoxDuo IR 48 biologic therapies 48 Chimigen 48 ZYTIGA 48 ZFP Therapeutic TM 48 Micromet proprietary BiTE 48 Long Term Efficacy 48 TaiGen 48 Celution System 48 IFN alfa 48 highly purified pasteurized 48 CentriMag 48 Resten MP 48 Granted Orphan Drug 48 TRO# 48 dabigatran etexilate 48 iCell Cardiomyocytes 48 neoadjuvant 48 AGGRASTAT ® 48 CIMZIA r 48 NTx 48 Medarex UltiMAb 48 BEMA TM 48 SparVax TM 48 tPEMF tm 48 HuCAL GOLD R 48 HepDirect R 48 Nebido 48 Dose Ranging Study 48 StemEx R 48 SUCCEED trial 48 HALO# [002] 48 Novacor II 48 CALGB # [002] 48 product Alferon N 48 recombinant fibrinogen 48 daily subcutaneous injections 48 Dacetuzumab 48 ELIQUIS 48 Nutra Pharma wholly owned 48 inhaled formulations 48 experimentally validated 48 DAPT 48 Lung Rx 48 Kosan dependence 48 Demineralized Bone Matrix 48 PROMACTA 48 mucopolysaccharidosis VI MPS VI 48 Viralytics 48 Hsp# chaperone inhibitor 48 Glybera R 48 soluble TNF receptor 48 Phage Pharmaceuticals 48 RLY# 48 Acute Ischemic Stroke 48 DuraHeart LVAS 48 QTinno 48 dacetuzumab 48 Ophthotech 48 somatotropin 48 Excellarate 48 ITAX 48 racemate 48 PharmFilm ® 48 Intraject 48 TAXUS Stent 48 Novasome 48 Lewy bodies DLB 48 BioSTAR R 48 laquinimod 48 APTIMA HPV assay 48 PROCRIT R 48 phage display technology 48 Metformin GR 48 oral transdermal 48 NeuroVive 48 Novosom 48 hyperimmune 48 statistically significant predictor 48 saphenous vein grafts 48 MyoCath